Evidence map›Paper›PMID 37514744›Full record

ArticleSensors (Basel, Switzerland)2023

CoSOV1Net: A Cone- and Spatial-Opponent Primary Visual Cortex-Inspired Neural Network for Lightweight Salient Object Detection.

Didier Ndayikengurukiye, Max Mignotte

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Didier NdayikengurukiyeDépartement d'Informatique et de Recherche Opérationnelle, Université de Montréal, Montreal, QC H3C 3J7, Canada.ORCID 0000-0003-1304-9842
Max MignotteDépartement d'Informatique et de Recherche Opérationnelle, Université de Montréal, Montreal, QC H3C 3J7, Canada.
Université de Montréal · CA

Funding

Natural Sciences and Engineering Research Council of Canada RGPIN-2022-03654
6 · The paper itself

Abstract

Salient object-detection models attempt to mimic the human visual system's ability to select relevant objects in images. To this end, the development of deep neural networks on high-end computers has recently achieved high performance. However, developing deep neural network models with the same performance for resource-limited vision sensors or mobile devices remains a challenge. In this work, we propose CoSOV1net, a novel lightweight salient object-detection neural network model, inspired by the cone- and spatial-opponent processes of the primary visual cortex (V1), which inextricably link color and shape in human color perception. Our proposed model is trained from scratch, without using backbones from image classification or other tasks. Experiments on the most widely used and challenging datasets for salient object detection show that CoSOV1Net achieves competitive performance (i.e., Fβ=0.931 on the ECSSD dataset) with state-of-the-art salient object-detection models while having a low number of parameters (1.14 M), low FLOPS (1.4 G) and high FPS (211.2) on GPU (Nvidia GeForce RTX 3090 Ti) compared to the state of the art in lightweight or nonlightweight salient object-detection tasks. Thus, CoSOV1net has turned out to be a lightweight salient object-detection model that can be adapted to mobile environments and resource-constrained devices.

Indexed as

color opponentcone-opponentdouble-opponentlightweight neural networklightweight salient object detectionobject detectionsalient object detectionvision sensing

Identifiers

PMID37514744
PMCPMC10386563
OpenAlexW4384525922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.